0001493152-24-020960.txt : 20240522 0001493152-24-020960.hdr.sgml : 20240522 20240522073512 ACCESSION NUMBER: 0001493152-24-020960 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20240522 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240522 DATE AS OF CHANGE: 20240522 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Sonnet BioTherapeutics Holdings, Inc. CENTRAL INDEX KEY: 0001106838 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 522102141 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-35570 FILM NUMBER: 24971646 BUSINESS ADDRESS: STREET 1: 100 OVERLOOK CENTER STREET 2: SUITE 102 CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: 609-375-2227 MAIL ADDRESS: STREET 1: 100 OVERLOOK CENTER STREET 2: SUITE 102 CITY: PRINCETON STATE: NJ ZIP: 08540 FORMER COMPANY: FORMER CONFORMED NAME: Chanticleer Holdings, Inc. DATE OF NAME CHANGE: 20050510 FORMER COMPANY: FORMER CONFORMED NAME: TULVINE SYSTEMS INC DATE OF NAME CHANGE: 20000214 8-K 1 form8-k.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 22, 2024

SONNET BIOTHERAPEUTICS HOLDINGS, INC.

(Exact name of registrant as specified in its charter)

Delaware

001-35570

20-2932652

(State or other jurisdiction

of incorporation)

(Commission

File Number)

(IRS Employer

Identification No.)

100 Overlook Center, Suite 102

Princeton, New Jersey

08540

(Address of principal executive office)

(Zip Code)

Registrant’s telephone number, including area code: (609) 375-2227

Not Applicable

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, $0.0001 par value per share		SONN		The Nasdaq Capital Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 8.01. Other Events.

On May 22, 2024, Sonnet BioTherapeutics Holdings, Inc. (the “Company”) issued a press release announcing that the Company’s Board of Directors has initiated a process to explore and review a range of strategic alternatives focused on maximizing stockholder value. A copy of the Company’s press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits:

Exhibit No.		Description
99.1		Press Release of Sonnet BioTherapeutics Holdings, Inc. issued May 22, 2024
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	SONNET BIOTHERAPEUTICS HOLDINGS, INC.

Date: May 22, 2024	By:	/s/ Pankaj Mohan, Ph.D.
	Name:	Pankaj Mohan, Ph.D.
	Title:	Chief Executive Officer

EX-99.1 2 ex99-1.htm

Exhibit 99.1

Sonnet BioTherapeutics Announces Review of Strategic Alternatives

PRINCETON, NJ / ACCESSWIRE / May 22, 2024 / Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) (the “Company” or “Sonnet”), a clinical-stage company developing targeted immunotherapeutic drugs, announced today that its Board of Directors has initiated a process to explore and review a range of strategic alternatives focused on maximizing stockholder value.

Sonnet has engaged Chardan Capital Markets, LLC (“Chardan”) to act as its financial advisor for this process. With assistance from Chardan and its other advisors, the Company will assess a full range of strategic alternatives, including but not limited to, business development, strategic partnerships, joint ventures, acquisitions, mergers, business combinations, in-licensing, or other strategic transactions.

The Company has not set a timetable for the conclusion of its review and has not made any decisions related to strategic alternatives at this time. The Company does not intend to comment further with respect to this review unless or until its Board of Directors has approved a definitive course of action, the review process has concluded, or it is determined that other disclosure is appropriate.

There can be no assurance that this evaluation will result in any definitive documentation to consummate one or more transactions, or other strategic changes or outcomes, or, that the terms of any such transactions, changes, or outcomes will be favorable. Even if the Company enters into a definitive agreement, the Company may not be successful in completing a transaction, change or outcome, or, if it completes such a transaction, change or outcome, it may not ultimately enhance value or deliver expected benefits.

About Sonnet BioTherapeutics Holdings, Inc.

Sonnet BioTherapeutics is an oncology-focused biotechnology company with a proprietary platform for innovating biologic drugs of single or bifunctional action. Known as F_HAB (Fully Human Albumin Binding), the technology utilizes a fully human single chain antibody fragment (scFv) that binds to and “hitch-hikes” on human serum albumin (HSA) for transport to target tissues. Sonnet’s F_HAB was designed to specifically target tumor and lymphatic tissue, with an improved therapeutic window for optimizing the safety and efficacy of immune modulating biologic drugs. F_HAB is the foundation of a modular, plug-and-play construct for potentiating a range of large molecule therapeutic classes, including cytokines, peptides, antibodies, and vaccines.

Forward-Looking Statements

This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 and Private Securities Litigation Reform Act, as amended, including those relating to the Company’s review of strategic alternatives, the Company’s ability to complete any transaction as a result of the strategic review process, the Company’s cash runway, the Company’s product development, clinical and regulatory timelines, market opportunity, competitive position, possible or assumed future results of operations, business strategies, potential growth opportunities and other statements that are predictive in nature. These forward-looking statements are based on current expectations, estimates, forecasts and projections about the industry and markets in which we operate and management’s current beliefs and assumptions.

These statements may be identified by the use of forward-looking expressions, including, but not limited to, “expect,” “anticipate,” “intend,” “plan,” “believe,” “estimate,” “potential,” “predict,” “project,” “should,” “would” and similar expressions and the negatives of those terms. These statements relate to future events or the Company’s financial performance and involve known and unknown risks, uncertainties, and other factors which may cause actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Such factors include those set forth in the Company’s filings with the Securities and Exchange Commission. Prospective investors are cautioned not to place undue reliance on such forward-looking statements, which speak only as of the date of this press release. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise.

Sonnet BioTherapeutics Investor Contact

Jack Yauch

Solebury Strategic Communications

862-754-1024

jyauch@soleburystrat.com

SOURCE: Sonnet BioTherapeutics Holdings, Inc.

EX-101.SCH 3 sonn-20240522.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 sonn-20240522_lab.xml XBRL LABEL FILE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 5 sonn-20240522_pre.xml XBRL PRESENTATION FILE XML 7 R1.htm IDEA: XBRL DOCUMENT

Cover	May 22, 2024
Cover [Abstract]
Document Type	8-K
Amendment Flag	false
Document Period End Date	May 22, 2024
Entity File Number	001-35570
Entity Registrant Name	SONNET BIOTHERAPEUTICS HOLDINGS, INC.
Entity Central Index Key	0001106838
Entity Tax Identification Number	20-2932652
Entity Incorporation, State or Country Code	DE
Entity Address, Address Line One	100 Overlook Center
Entity Address, Address Line Two	Suite 102
Entity Address, City or Town	Princeton
Entity Address, State or Province	NJ
Entity Address, Postal Zip Code	08540
City Area Code	(609)
Local Phone Number	375-2227
Written Communications	false
Soliciting Material	false
Pre-commencement Tender Offer	false
Pre-commencement Issuer Tender Offer	false
Title of 12(b) Security	Common Stock, $0.0001 par value per share
Trading Symbol	SONN
Security Exchange Name	NASDAQ
Entity Emerging Growth Company	false

EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1.1.u2 html 1 23 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://sonnetbio.com/role/Cover Cover Cover 1 false false All Reports Book All Reports form8-k.htm sonn-20240522.xsd sonn-20240522_lab.xml sonn-20240522_pre.xml http://xbrl.sec.gov/dei/2024 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "form8-k.htm": { "nsprefix": "SONN", "nsuri": "http://sonnetbio.com/20240522", "dts": { "inline": { "local": [ "form8-k.htm" ] }, "schema": { "local": [ "sonn-20240522.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd", "https://xbrl.sec.gov/country/2024/country-2024.xsd", "https://xbrl.sec.gov/dei/2024/dei-2024.xsd", "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd" ] }, "labelLink": { "local": [ "sonn-20240522_lab.xml" ] }, "presentationLink": { "local": [ "sonn-20240522_pre.xml" ] } }, "keyStandard": 23, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2024": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 59, "unitCount": 3, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2024": 23 }, "report": { "R1": { "role": "http://sonnetbio.com/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "AsOf2024-05-22", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form8-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-05-22", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form8-k.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AmendmentDescription", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AmendmentFlag", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AnnualInformationForm", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r14" ] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r14" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CityAreaCode", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CountryRegion", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentAccountingStandard", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentAnnualReport", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r11", "r13", "r14" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentPeriodEndDate", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentPeriodStartDate", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentQuarterlyReport", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r12" ] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentRegistrationStatement", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r0" ] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentShellCompanyReport", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentTransitionReport", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r15" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentType", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r3" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine1", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine2", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine3", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressCityOrTown", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressCountry", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r6" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCentralIndexKey", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r2" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r2" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityExTransitionPeriod", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r19" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityFileNumber", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityFilerCategory", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r2" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r16" ] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityPrimarySicNumber", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r14" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityRegistrantName", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r2" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityShellCompany", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r2" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntitySmallBusiness", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r2" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r2" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityVoluntaryFilers", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r17" ] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Extension", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "LocalPhoneNumber", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "NoTradingSymbolFlag", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r13" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r7" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PreCommencementTenderOffer", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r9" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Security12bTitle", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r1" ] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Security12gTitle", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r5" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SecurityExchangeName", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r4" ] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SecurityReportingObligation", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r10" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SolicitingMaterial", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r8" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "TradingSymbol", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "WrittenCommunications", "presentation": [ "http://sonnetbio.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r18" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r8": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14a", "Subsection": "12" }, "r9": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r10": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r11": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r12": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r13": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r14": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r15": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r16": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r17": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r18": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r19": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 15 0001493152-24-020960-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-24-020960-xbrl.zip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end XML 17 form8-k_htm.xml IDEA: XBRL DOCUMENT 0001106838 2024-05-22 2024-05-22 iso4217:USD shares iso4217:USD shares false 0001106838 8-K 2024-05-22 SONNET BIOTHERAPEUTICS HOLDINGS, INC. DE 001-35570 20-2932652 100 Overlook Center Suite 102 Princeton NJ 08540 (609) 375-2227 false false false false Common Stock, $0.0001 par value per share SONN NASDAQ false